129 related articles for article (PubMed ID: 18687789)
1. A pseudo-full mutation identified in fragile X assay reveals a novel base change abolishing an EcoRI restriction site.
Liang S; Bass HN; Gao H; Astbury C; Jamehdor MR; Qu Y
J Mol Diagn; 2008 Sep; 10(5):469-74. PubMed ID: 18687789
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
5. A novel polymorphism in the FMR1 gene: implications for clinical testing of fragile X syndrome.
Thyagarajan B; Bower M; Berger M; Jones S; Dolan M; Wang X
Arch Pathol Lab Med; 2008 Jan; 132(1):95-8. PubMed ID: 18181681
[TBL] [Abstract][Full Text] [Related]
6. A methylation PCR approach for detection of fragile X syndrome.
Panagopoulos I; Lassen C; Kristoffersson U; Aman P
Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
[TBL] [Abstract][Full Text] [Related]
7. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male.
Han XD; Powell BR; Phalin JL; Chehab FF
Am J Med Genet A; 2006 Jul; 140(13):1463-71. PubMed ID: 16761284
[TBL] [Abstract][Full Text] [Related]
8. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
[TBL] [Abstract][Full Text] [Related]
9. Mosaicism for an FMR1 gene deletion in a fragile X female.
Fan H; Booker JK; McCandless SE; Shashi V; Fleming A; Farber RA
Am J Med Genet A; 2005 Jul; 136(2):214-7. PubMed ID: 15940701
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.
Snow K; Doud LK; Hagerman R; Pergolizzi RG; Erster SH; Thibodeau SN
Am J Hum Genet; 1993 Dec; 53(6):1217-28. PubMed ID: 7902673
[TBL] [Abstract][Full Text] [Related]
11. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610
[TBL] [Abstract][Full Text] [Related]
12. Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.
Fatima T; Zaidi SA; Sarfraz N; Perween S; Khurshid F; Imtiaz F
Am J Med Genet A; 2014 May; 164A(5):1151-61. PubMed ID: 24478267
[TBL] [Abstract][Full Text] [Related]
13. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
Chen L; Hadd A; Sah S; Houghton JF; Filipovic-Sadic S; Zhang W; Hagerman PJ; Tassone F; Latham GJ
Genet Med; 2011 Jun; 13(6):528-538. PubMed ID: 21430544
[TBL] [Abstract][Full Text] [Related]
14. [Tissue heterogeneity analysis of CGG-repeat mutation in two fragile X affected male fetuses].
Huang W; Luo SY; Du Q; Yang P; Tan H; Wu LQ; Duan RH
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):287-9. PubMed ID: 27055429
[TBL] [Abstract][Full Text] [Related]
15. Direct molecular analysis of the fragile X syndrome in a sample of Egyptian and German patients using non-radioactive PCR and Southern blot followed by chemiluminescent detection.
el-Aleem AA; Böhm I; Temtamy S; el-Awady M; Awadalla M; Schmidtke J; Stuhrmann M
Hum Genet; 1995 Nov; 96(5):577-84. PubMed ID: 8530006
[TBL] [Abstract][Full Text] [Related]
16. Use of methylation sensitive polymerase chain reaction for detection of fragile X full mutation & carrier state in males.
Karunasagar A; Pandit L; Kumar S; Karunasagar I; Karunasagar I
Indian J Med Res; 2005 Nov; 122(5):429-33. PubMed ID: 16456258
[TBL] [Abstract][Full Text] [Related]
17. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome.
Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of Fragile X syndrome.
Sofocleous C; Kolialexi A; Mavrou A
Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of fragile X syndrome.
Nolin SL; Dobkin C; Brown WT
Curr Protoc Hum Genet; 2003 Nov; Chapter 9():Unit9.5. PubMed ID: 18428348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
